Skip to main content
. 2022 May 2;14:319–332. doi: 10.2147/CEOR.S357540

Table 3.

Top 10 Reasons for Hospitalization in PS-Matched Cohorts

Reason for Hospitalization (ICD-10 Code for Main Diagnosis) Number of Events per 100 PYs (95% CI)
EMPA (Matched to DPP-4i) DPP-4i EMPA (Matched to GLP-1-RA) GLP-1-RA
N 3100 3100 1346 1346
Any hospitalization 35.45 (33.73–37.20) 45.67 (44.22–47.12) 31.94 (29.49–34.51) 40.14 (37.73–42.59)
 T2DM (E11) 2.30 (1.82–2.91) 2.28 (1.18–2.75) 3.26 (2.43–4.36) 2.88 (2.16–3.83)
 Heart failure (I50) 1.31 (0.95–1.79) 2.54 (2.12–3.04) 0.76 (0.41–1.39) 1.60 (1.09–2.35)
 CHD (I25) 1.58 (1.19–2.10) 1.59 (1.27–2.00) 0.91 (0.52–1.58) 0.96 (0.58–1.58)
 Angina Pectoris (I20) 1.51 (1.13–2.02) 1.48 (1.17–1.88) 1.29 (0.81–2.05) 1.02 (0.63–1.66)
 Ischemic stroke (I63) 1.27 (0.92–1.75) 0.80 (0.58–1.10) 0.53 (0.26–1.09) 1.28 (0.83–1.97)
 Atherosclerosis (I70) 1.06 (0.75–1.51) 0.86 (0.63–1.18) 0.61 (0.31–1.19) 0.64 (0.35–1.17)
 Atrial fibrillation (I48) 0.69 (0.45–1.06) 0.97 (0.73–1.30) 0.91 (0.52–1.58) 0.64 (0.35–1.17)
 Myocardial infarction (I21) 0.93 (0.64–1.35) 1.04 (0.78–1.38) 1.21 (0.75–1.96) 0.38 (0.18–0.84)
 Dorsalgia (M54) 0.62 (0.39–0.98) 0.80 (0.58–1.10) 0.91 (0.52–1.58) 0.83 (0.49–1.42)
 Sleep disorders (G47) 0.86 (0.58–1.26) 0.60 (0.41–0.87) 0.38 (0.16–0.88) 1.34 (0.88–2.05)

Abbreviations: CHD, coronary heart disease; CI, confidence interval; DPP-4i, dipeptidyl peptidase-4 inhibitor; EMPA, empagliflozin; GLP-1-RA, glucagon-like peptide-1 receptor agonists; PY, person-year; T2DM, type 2 diabetes mellitus.